Tourette syndrome: From a neurological clinic to a multidisciplinary approach

Harefuah

Volumn 145, Issue 4, 2006, Pages 292-297

  Benarroch, Fortu ^a   Warman, Orly ^a   Gross Tsur, Varda ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

ADHD; Comorbidity; OCD; Tic; Tourette

Indexed keywords

CHILD; FAMILY; GILLES DE LA TOURETTE SYNDROME; HUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PSYCHOLOGICAL ASPECT; REVIEW;

CHILD; FAMILY; HUMANS; PATIENT CARE TEAM; TOURETTE SYNDROME;

EID: 33646831328     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Kurlan R, Como PG, Miller B & al, The behavioral spectrum of tic disorders: a community based study. Neurology, 2002; 59: 414-420.
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-4). Washington DC, APA, 1994.
3. Singer HS, Tourette's syndrome: from behaviour to biology. Lancet Neurol, 2005; 4: 149-59.
4. Bjorn K & Gillberg C, Tourette's disorder: epidemilogy and comorbidity in primary school children. J Am Acad Child Adolesc Psychiatry, 2000; 39: 548-55.
5. Apter A, Pauls DL, Bleich A & al, An epidemiologic study of Gilles de Tourette's syndrome in Israel. Ach Gen Psychiatry, 1993; 50: 734-738.
6. Freeman RD, Fast DK, Burd L & al, An international perspective on Tourette syndrome: selected findings from 3500 individuals in 22 countries. Develop Med Child Neurol, 2000; 42: 436-447.
7. Demirkiran M & Jankovic J, Paroxismal dyskinesias: clinical features and classification. Ann Neurol, 1995; 38: 571-79.
8. Alonso H, Cubo-Delgado E, Mateos-Beato MP & al, Huntington's disease mimicking Tourette syndrome. Rev Neurol, 2000; 39: 927-9.
9. Eisenberg J, Wahrman O, Bamberger E & Greenberg D, Psychogenic cough tic: a case report. Isr J Psychiatry Relat Sci, 1997; 34: 235-8.
10. Leckman JF, King RA, Scahill L & al, Yale approach to assessment and treatment. In: Leckman JF & Cohen DJ, (Eds). Tourette's Syndrome Tics, Obsessions, Compulsions: Developmental Psychopathology and Clinical Care. New York, John Wiley and Sons, 1998, pp 285-309.
11. Leckman JF, Pauls DL, Zhang H & al, Tourette Syndrome Assocation International Consortium for Genetics. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. Am J Med Genet, 2003; 116B: 60-8.
12. Channon S, Pratt P & Robertson MM, Executive function, memory, and learning in Tourette's syndrome. Neuropsychology, 2003; 17: 247-54.
13. Schultz RT, Carter AS, Gladstone M & al, Visual-motor integration functioning in children with Tourette syndrome. Neuropsychology, 1998; 12: 134-45.
14. Carter AS, O'Donell DA, Schutz RT & al, Social and emotional adjustment in children affected with Gilles de la Tourette syndrome: associations with ADHD and family functioning. J Child Psychol Psychiatry, 2000; 41: 215-233.
15. Budman CL, Bruun RD, Park KS & al, Explosive outbursts in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry, 2000; 39: 1270-76.
16. Kostanecka-Endress T, Banaschewski T, Kinkelbur J & al, Disturbed sleep in children with Tourette syndrome: a polysomnographic study. J Psychosom Res, 2003; 55: 23-9.
17. Sukhodolsky DG, Scahill L, Zhang H & al, Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity and functional impairment. J Am Acad Child Adolesc Psychiatry, 2002; 42: 98-105.
18. Coffey BJ, Biederman J, Geller DA & al, Distinguishing illness severity from tic severity in children and adolescents with Tourette disorder. J Am Acad Child Adolesc Psychiatry, 2000; 39: 556-561.
19. Coffey BJ, Biederman J, Smoller JW & al, Anxiety disorders and tic severity in juveniles with Tourette's disorder. J Am Acad Child Adolesc Psychiatry, 2000; 39: 562-68.
20. Leckman JF, Zhang H, Vitale A & al, Course of tic severity in Tourette's syndrome: the first two decades. Pediatrics, 1998; 102: 14-19.
21. Burd L, Kerbeshian L, Barth A & al, Long-term follow-up of an epidemiologically defined cohort of patients with Tourette's syndrome. J Child Neurol, 2001; 16: 431-437.
22. Peterson BS & Cohen DJ, The treatment of Tourette's syndrome: multimodal developmental intervention. J Clin Psychiatry, 1998; 59 (suppl 1): 62-72.
23. Pauls DL, An update on the genetics of Gilles de la Tourette syndrom. J Psychosom Res, 2003; 55: 7-12.
24. McMahon WM, Carter AS, Fredine N & Pauls DL, Children at familial risk for Tourette's disorder: child and parent diagnoses. Am J Med Genet, 2003; 121B: 105-11.
25. Marsh R, Alexander GM, Packard MG & al, Habit learning in Tourette syndrome: a translational neuroscience approach to a developmental psychopathology. Arch Gen Psychiatry, 2004; 61: 1259-68.
26. Berardelli A, Curr A, Fabbrini G & al, Pathophysiology of tics and Tourette syndrome. J Neurol, 2003; 250: 781-787.
27. Peterson BS, Thomas P, Kane MJ & al, Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry, 2003; 60: 415-24.
28. Muller-Vahl KR, Berding G, Kolbe H & al, Dopamine D2 receptor imaging in Gilles de la Tourette syndrome. Acta-Neurol-Scand, 2000; 101: 165-71.
29. Hoekstra PJ, Kallenberg CG, Korf J & Minderaa RB, Is Tourette's syndrome an autoimmune disease? Mol Psychiatry, 2002; 7: 437-45.
30. King RA, Scahill L, Findley D & Cohen DJ, Psychosocial and behavioral treatments. In: Leckman JF & Cohen DJ, (Eds). Tourette's Syndrome: Tics, Obsessions, Compulsions, 1999. New York; Wiley, pp. 338-59.
31. Wilhelm S, Deckersbach T, Coffey BJ & al, Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry, 2003; 160: 1175-7.
32. Shapiro E, Shapiro AK, Fulop G & al, Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry, 1989; 46: 722-30.
33. Robertson MM, Schnieden V & Lees AJ, Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol, 1990; 13: 229-35.
34. Scahill H, Leckman JF, Schultz RT & al, A Placebo-Controlled Trial of Risperidone in Tourette Syndrome. Neurology, 2003; 60: 1130-5.
35. Tourette's Syndrome Study Group, Treatment of ADHD in children with tics: a randomized controlled trial. Neurology, 2002; 58: 527-36.
36. Cianchetti C, Fratta A, Pisano T & Minafra L, Pergolide improvement in neuroleptic-resistant Tourette cases: various mechanisms causing tics. Neurol Sci, 2005; 26: 137-9.
37. Anca MH, Giladi N & Korczyn AD, Ropinirole in Gilles de la Tourette syndrome. Neurology, 2004; 62: 1626-7.
38. Toren P, Weizman A, Ratner S & al, Ondansetron treatment in Tourette's disorder: a 3 week, randomized, double-blind, placebo controlled study. J Chn Psychiatry, 2005; 66: 499-503.
39. Visser-Vandewalle V, Temel Y, Boon P & al, Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg, 2003; 99: 1094-100.
40. Gadow RD, Sverd J, Sprafkin J & al, Long term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Arch Gen Psychiatry, 1999; 56: 330-36.